Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 JUL 27 ... According to a study from Suita, Japan, "The antiviral effect of adefovir dipivoxil (ADV) added to ongoing lamivudine (LAM) treatment for LAM-resistant chronic hepatitis B ...
2009 APR 13 ... 'Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy.' "Lamivudine (LAM) resistance is frequently associated with various types ...
2009 AUG 24 ... and octadecyloxyethyl (ODE) esters and compared their activities with the activity of adefovir dipivoxil in vitro and in vivo." "Alkoxyalkyl esters of (S)-HPMPA were 6 to 20 ...
2009 MAR 9 ... Current study results from the report, 'Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in ...
2009 JUN 15 ... B e antigen seroconversion. Telbivudine was also proved to be superior to lamivudine and adefovir dipivoxil. This article provides an overview of the pharmacokinetics, clinical efficacies, ...
2009 AUG 3 ... product sales, including Viread® (tenofovir disoproxil fumarate), Hepsera® (adefovir dipivoxil) and Emtriva® (emtricitabine), decreased six percent to $233.1 million for the ...
2009 NOV 2 ... Other Antiviral Products Other antiviral product sales which consist of Hepsera® (adefovir dipivoxil) and Emtriva® (emtricitabine) were $74.7 million for the third quarter of 2009. ...
2009 FEB 16 ... France, "In patients with hepatitis B e antigen-negative chronic hepatitis B, adefovir dipivoxil administration selects variants bearing reverse transcriptase rtN236T and/or rtA181V/T ...
2009 AUG 3 ... should be avoided. Viread should not be administered in combination with Hepsera® (adefovir dipivoxil). Viread should only be used as part of an appropriate antiretroviral ...
2009 JUN 15 ... was to verify the usefulness of the roadmap concept to predict clinical outcomes of adefovir dipivoxil monotherapy in hepatitis B e antigen (HBeAg)-positive patients with lamivudine ...
2009 OCT 19 ... from the United States, "Renal dysfunction has been reported in patients treated with adefovir dipivoxil (ADV); however, its incidence and clinical importance may be underappreciated given the ...
2009 AUG 17 ... According to a study from Tainan, Taiwan, "Adefovir dipivoxil treatment leads to higher HBeAg seroconversion rates than placebo. The study was to ...
2009 JUN 15 ... Currently, seven drugs are available: IFN-alpha, pegylated interferon, lamivudine, adefovir dipivoxil, entecavir, telbivudine and tenofovir."
"The choice of the drugs ...
2009 MAY 4 ... B e antigen (HBeAg)-positive chronic HBV who received, sequentially, lamivudine (LAM), adefovir dipivoxil (ADV), and ADV + telbivudine (LDT) combination treatment over a total of 108 weeks. A ...
2009 SEP 28 ... kinetics) to treatment response in chronic hepatitis B (CHB) and first-line therapy with adefovir dipivoxil (ADV). Sixty-six patients (60% males, 65% HBeAg negative) were treated with 10 mg ADV ...
2009 AUG 31 ... New investigation results, 'Pharmacokinetics of tacrolimus co-administered with adefovir dipivoxil to liver transplant recipients,' are detailed in a study published in Liver ...
2009 MAR 23 ... According to a study from Lyon, France, "Data on the efficacy of adefovir dipivoxil (ADV) in elderly and cirrhotic patients with lamivudine-resistant (LAM-R) chronic ...
2009 MAR 23 ... Scientists discuss in 'A short course of add-on adefovir dipivoxil treatment in lamivudine-resistant chronic hepatitis B patients' new findings in ...
